Alexandra Walsh Named Law 360 Trials MVP of the Year

wwe Homepage news, News, News, Uncategorized

WASHINGTON – Wilkinson Walsh + Eskovitz Founding Partner Alexandra Walsh was named one of Law360’s 2019 Trial MVPs of the Year. The award recognizes Walsh for leading “trial teams to a string of crucial victories for Bayer AG this year, persuading juries to reject a certified class action attacking the company’s One A Day vitamins as well as suits over its blood thinner Xarelto.” In an interview with Law360, Walsh said that the successful defense verdict for Bayer in a $600 million certified consumer class action lawsuit regarding the company’s One A Day vitamins was her biggest accomplishment and biggest challenge of the year. The victory has been lauded as an “all-out win” due to WW+E’s “confidence and strategy.” Law360 also recognized Walsh for her role defending Bayer in a series of bellwether trials over its blood thinner Xarelto. “Alex’s win reflects what we at WW+E see every day: the …

American Healthcare Leader: “Wilkinson Walsh + Eskovitz Help Bayer Stand Its Ground”

wwe Homepage news, News, News

WASHINGTON — After the WW+E team won a decisive trial victory for Bayer in a $600 million certified consumer class action lawsuit brought on behalf of One A Day multivitamin consumers, American Healthcare Leader’s (AHL) Sara Deeter highlighted how Walsh and Eskovitz’s “confidence and strategy” helped Bayer win a “resounding victory” in such a “high stakes” case. Without calling any witnesses in the defense case, the WW+E team — led by Sean Eskovitz, Alex Walsh, James Rosenthal, and Kieran Gostin — relied on devastating cross-examinations of plaintiffs’ expert and fact witnesses, which were “pivotal” and “yielded further important insights.” The cross-examinations were so effective that it only took the jury one hour to reject plaintiffs’ claims that Bayer had misrepresented the health benefits of One A Day multivitamins.  The feature acknowledged one of WW+E’s key strategies to engaging with the jury in a case that centered on “relatively complicated biological …

WW+E’s Beth Wilkinson, Alex Walsh Again Named “Top Women in Litigation” by Benchmark

wwe Homepage news, News, News

WASHINGTON – For the second consecutive year, Wilkinson Walsh + Eskovitz founding partners Beth Wilkinson and Alexandra Walsh were ranked among Benchmark Litigation’s “Top 250 Women in Litigation,” a recognition of “the most distinguished women in the world of litigation.” In addition, Beth Wilkinson was again named among the “Top 10 Female Litigators” in the country, which recognizes “a separate but elite group of leading lawyers who have been nominated specifically for their litigious acumen.” “Beth and Alex’s repeated recognition by Benchmark is a testament to their leadership at our firm and their expertise in the courtroom,” said WW+E Managing Partner Brant Bishop. “In an industry that continues to suffer from an underrepresentation of women – especially in leadership roles – we are proud to have trailblazers like Beth and Alex.” Benchmark’s extensive research process encompasses months of investigation into the individual litigators’ professional activities as well as client feedback surveys and …

WW+E Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers

wwe Homepage news, News, News

WASHINGTON – Wilkinson Walsh + Eskovitz is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of WW+E’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. WW+E won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, WW+E, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, WW+E, led by Kosta Stojilkovic and Rakesh …

WWE PARTNER ALEXANDRA WALSH NAMED LITIGATOR OF THE WEEK

wwe Homepage news, News, News

Award recognizes her role leading the Wilkinson, Walsh + Eskovitz team to another victory WASHINGTON – Litigation Daily selected Wilkinson Walsh + Eskovitz Founding Partner Alexandra Walsh as its Litigator of the Week for her role persuading a Philadelphia jury to find for the defense in a bellwether trial over the adequacy of the warning labels for the blood thinner Xarelto. Walsh, along with partners Tamarra Matthews Johnson and Rakesh Kilaru, won the third state-court bellwether trial over the blood- thinner Xarelto in the Pennsylvania Court of Common Pleas in August. The victory was the third win for Bayer in state court, and the sixth win overall, in the Xarelto litigation. Read her Q&A with Lit Daily Editor Jenna Greene here. Walsh and Johnson served as lead trial counsel for Bayer, and Kilaru helped direct the legal strategy. A 12-member jury in Philadelphia returned a defense verdict after less than …